Rare variants with large effects provide functional insights into the pathology of migraine subtypes, with and without aura

Gyda Bjornsdottir*, Mona A. Chalmer, Lilja Stefansdottir, Astros Th Skuladottir, Gudmundur Einarsson, Margret Andresdottir, Doruk Beyter, Egil Ferkingstad, Solveig Gretarsdottir, Bjarni V. Halldorsson, Gisli H. Halldorsson, Anna Helgadottir, Hannes Helgason, Grimur Hjorleifsson Eldjarn, Adalbjorg Jonasdottir, Aslaug Jonasdottir, Ingileif Jonsdottir, Kirk U. Knowlton, Lincoln D. Nadauld, Sigrun H. LundOlafur Th Magnusson, Pall Melsted, Kristjan H.S. Moore, Asmundur Oddsson, Pall I. Olason, Asgeir Sigurdsson, Karina Banasik, Søren Brunak, Maria Didriksen, Lisette J.A. Kogelman, Kaspar R. Nielsen, Erik Sørensen, Ole B. Pedersen, Henrik Ullum, Jakob Bay, Kristoffer Burgdorf, Joseph Dowsett, Henrik Hjalgrim, Rikke L. Jacobsen, Ioannis Louloudis, Agnete Lundgaard, Christina Mikkelsen, Mette Nyegaard, Alexander P. Henriksen, Thomas Werge, David Westergaard, Jes Olesen, Sisse R. Ostrowski, Thomas F. Hansen, DBDS Genetic Consortium

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

14 Citations (Scopus)
17 Downloads (Pure)

Abstract

Migraine is a complex neurovascular disease with a range of severity and symptoms, yet mostly studied as one phenotype in genome-wide association studies (GWAS). Here we combine large GWAS datasets from six European populations to study the main migraine subtypes, migraine with aura (MA) and migraine without aura (MO). We identified four new MA-associated variants (in PRRT2, PALMD, ABO and LRRK2) and classified 13 MO-associated variants. Rare variants with large effects highlight three genes. A rare frameshift variant in brain-expressed PRRT2 confers large risk of MA and epilepsy, but not MO. A burden test of rare loss-of-function variants in SCN11A, encoding a neuron-expressed sodium channel with a key role in pain sensation, shows strong protection against migraine. Finally, a rare variant with cis-regulatory effects on KCNK5 confers large protection against migraine and brain aneurysms. Our findings offer new insights with therapeutic potential into the complex biology of migraine and its subtypes.

Original languageEnglish
JournalNature Genetics
Volume55
Issue number11
Pages (from-to)1843-1853
ISSN1061-4036
DOIs
Publication statusPublished - 2023

Bibliographical note

Publisher Copyright:
© 2023, The Author(s).

Cite this